Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma

This study has suspended participant recruitment.
(Temporarily on hold)
Sponsor:
Collaborators:
National Comprehensive Cancer Network
Information provided by (Responsible Party):
University of Washington
ClinicalTrials.gov Identifier:
NCT00823797
First received: January 15, 2009
Last updated: October 6, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)